Galderma Expands Restylane Portfolio in Japan With Launch of OBT Hyaluronic Acid Injectables Restylane Defyne and Refyne

Restylane Refyne and Restylane Defyne are the first Optimal Balance Technology (OBT) hyaluronic acid injectables ever approved and launched in Japan, bringing advanced flexibility and natural movement ...
Morningstar

Galderma Unveils ‘Wake Up To Restylane’, Underscoring Restylane as the Ideal Hyaluronic Acid Treatment for Always-On Natural Beauty

Galderma (SIX: GALD), the pure-play dermatology category leader, has launched ‘Wake Up To Restylane’, a global campaign that showcases Restylane as an everyday beauty ally. Aligned with the growing ...
Morningstar

ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it presented new data from its Injectable Aesthetics portfolio and pipeline at the American Society for ...
Pharmabiz

Galderma launches OBT hyaluronic acid injectables Restylane Defyne and Refyne in Japan

Galderma launches OBT hyaluronic acid injectables Restylane Defyne and Refyne in Japan: Zug, Switzerland Thursday, February 12, 2026, 13:00 Hrs [IST] Galderma, the pure-play derma ...